Note: EPS may not be comparable

aTyr Pharma (NASDAQ: LIFE) reported Q4 EPS of ($0.39), $0.02 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.